Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 18 Apr 2023 08:37 CEST |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |
| 18 Apr 2023 08:36 CEST |
TITAN CEMENT | Share buyback programme | 50101030 Cement | Other subject |
| 18 Apr 2023 08:00 CEST |
KBC | KBC Groep: KBC maakt de impact van IFRS 17 op de resultatenrekening bekend met aangepaste vergelijkende resultaten, belangrijke ratio's en verwachtingen op korte en lange termijn. | 30101010 Banks | Commercial results |
| 18 Apr 2023 08:00 CEST |
KBC | KBC Group: KBC discloses the impact of IFRS 17 on the income statement with restated comparative results, key ratios and short-term and long-term financial guidance | 30101010 Banks | Commercial results |
| 18 Apr 2023 08:00 CEST |
KBC | KBC Groupe: KBC communique l'impact de la norme IFRS 17 sur le compte de résultats avec des résultats comparatifs, ratios clés et prévisions financières à court et à long terme retraités | 30101010 Banks | Commercial results |
| 18 Apr 2023 07:00 CEST |
BIOSENIC | BioSenic receives key European patent from EPO, for further therapeutic development in cancer, infectious and immune diseases | 20103010 Biotechnology | Other subject |
| 18 Apr 2023 07:00 CEST |
HYLORIS | Hyloris announces submission of Maxigesic® IV packaging data requested by the US FDA | 20103010 Biotechnology | Products and services |
| 18 Apr 2023 07:00 CEST |
BIOSENIC | BioSenic reçoit un brevet européen clé de l'OEB pour le développement de thérapies contre les cancers, et les maladies infectieuses et immunitaires | 20103010 Biotechnology | Other subject |
| 18 Apr 2023 07:00 CEST |
HYLORIS | Hyloris annonce la soumission des données relatives au conditionnement de Maxigesic® IV demandées par la FDA aux Etats-Unis | 20103010 Biotechnology | Products and services |
| 18 Apr 2023 07:00 CEST |
ARGENX SE | argenx Demonstrates Commitment to Redefining Treatment Goals for Generalized Myasthenia Gravis with Multiple Presentations at American Academy of Neurology 2023 Annual Meeting | 20103010 Biotechnology | Other subject |
| 17 Apr 2023 22:30 CEST |
NYXOAH SA | Information on the Total Number of Voting Rights and Shares | 20102010 Medical Equipment | Change in Capital |
| 17 Apr 2023 22:30 CEST |
NYXOAH SA | Informations sur le Nombre Total de Droits de Vote et d'Actions | 20102010 Medical Equipment | Change in Capital |
| 17 Apr 2023 22:15 CEST |
EURONAV | Euronav Annual General Meeting of 17 May 2023 | 50206030 Marine Transportation | Other subject |
| 17 Apr 2023 22:15 CEST |
EURONAV | Euronav – Jaarlijkse Algemene Vergadering van 17 mei 2023 | 50206030 Marine Transportation | Other subject |
| 17 Apr 2023 18:30 CEST |
IEP INVEST | Gewone algemene vergadering van 24 mei 2023 | 35101010 Real Estate Holding and Development | General meeting / Board Meeting |
| 17 Apr 2023 18:30 CEST |
IEP INVEST | Buitengewone algemene vergadering van 24 mei 2023 | 35101010 Real Estate Holding and Development | General meeting / Board Meeting |
| 17 Apr 2023 18:30 CEST |
IEP INVEST | Jaarverslag 2022 | 35101010 Real Estate Holding and Development | Other subject |
| 17 Apr 2023 18:07 CEST |
GBL | GBL - Transacties op GBL-aandelen 17-04-2023 | 30202000 Diversified Financial Services | Other financial transaction |
| 17 Apr 2023 18:05 CEST |
GBL | GBL - Transactions sur actions propres 17-04-2023 | 30202000 Diversified Financial Services | Other financial transaction |
| 17 Apr 2023 18:05 CEST |
ACCENTIS | Oproeping Gewone Algemene Vergadering van 23 mei 2023 | 35101010 Real Estate Holding and Development | General meeting / Board Meeting |
| 17 Apr 2023 18:04 CEST |
GBL | GBL - Transactions on GBL shares 17-04-2023 | 30202000 Diversified Financial Services | Other financial transaction |
| 17 Apr 2023 18:00 CEST |
ECONOCOM GROUP | ECONOCOM: Q1 2023 revenue growth: 10.3% including 4.4% organic growth | 10101010 Computer Services | Sales, Income, Commercial results |
| 17 Apr 2023 18:00 CEST |
ECONOCOM GROUP | ECONOCOM: Croissance du chiffre d'affaires au 1er trimestre 2023 : +10,3%, dont +4,4% organique | 10101010 Computer Services | Sales, Income, Commercial results |
| 17 Apr 2023 18:00 CEST |
ACCENTIS | Jaarverslag 2022 | 35101010 Real Estate Holding and Development | Other subject |
| 17 Apr 2023 08:00 CEST |
ARGENX SE | argenx and Genmab Enter Partnership to Advance Antibody Therapies in Immunology and Oncology | 20103010 Biotechnology | Other subject |
| 14 Apr 2023 17:40 CEST |
AGEAS | Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV | 30301010 Life Insurance | Other financial transaction |
| 14 Apr 2023 17:40 CEST |
AGEAS | Ageas annonce les Assemblées Générales Ordinaire et Extraordinaire des Actionnaires d’ageas SA/NV | 30301010 Life Insurance | Other financial transaction |
| 14 Apr 2023 17:40 CEST |
AGEAS | Ageas kondigt de Gewone en Buitengewone Algemene Vergaderingen van Aandeelhouders van ageas SA/NV aan | 30301010 Life Insurance | Other financial transaction |
| 14 Apr 2023 08:15 CEST |
BEKAERT | Bekaert - Mise à jour relative au Programme de Rachat d’Actions et au Contrat de Liquidité | 55102010 Iron and Steel | Legal |
| 14 Apr 2023 08:15 CEST |
BEKAERT | Bekaert - Update over het Inkoop van Eigen Aandelen Programma en de Liquiditeitsovereenkomst | 55102010 Iron and Steel | Legal |
| 14 Apr 2023 08:15 CEST |
BEKAERT | Bekaert - Update on the Share Buyback Program and the Liquidity Agreement | 55102010 Iron and Steel | Legal |
| 14 Apr 2023 06:30 CEST |
EVS BROADC.EQUIPM. | EVS INVITE SES ACTIONNAIRES À L'ASSEMBLÉE GÉNÉRALE ORDINAIRE ET À UNE ASSEMBLÉE GÉNÉRALE EXTRAORDINAIRE LE 16 MAI 2023 | 15101010 Telecommunications Equipment | Corporate life |
| 14 Apr 2023 06:30 CEST |
EVS BROADC.EQUIPM. | EVS INVITES ITS SHAREHOLDERS TO THE ORDINARY GENERAL MEETING AND AN EXTRAORDINARY GENERAL MEETING ON MAY 16, 2023 | 15101010 Telecommunications Equipment | Corporate life |
| 13 Apr 2023 22:05 CEST |
NYXOAH SA | Nyxoah Raises $3 Million from its At-the-Market Equity Offering | 20102010 Medical Equipment | Change in Capital |
| 13 Apr 2023 22:05 CEST |
NYXOAH SA | Nyxoah Lève 3 Millions de Dollars dans le Cadre de son Offre d'Actions At-The-Market | 20102010 Medical Equipment | Change in Capital |
| 13 Apr 2023 18:11 CEST |
GBL | GBL - Transparantieverklaring | 30202000 Diversified Financial Services | Legal |
| 13 Apr 2023 18:09 CEST |
GBL | GBL - Déclaration de transparence | 30202000 Diversified Financial Services | Legal |
| 13 Apr 2023 18:08 CEST |
GBL | GBL - Transparency declaration | 30202000 Diversified Financial Services | Legal |
| 13 Apr 2023 18:00 CEST |
BEKAERT | Bekaert: Openbaarmaking transparantiekennisgeving | 55102010 Iron and Steel | Legal |
| 13 Apr 2023 18:00 CEST |
BEKAERT | Bekaert: Publication transparency notification | 55102010 Iron and Steel | Legal |
| 13 Apr 2023 18:00 CEST |
BEKAERT | Bekaert: Publication notification de transparence | 55102010 Iron and Steel | Legal |
| 13 Apr 2023 17:45 CEST |
AZELIS GROUP NV | Azelis Group NV: Transparantiekennisgeving | 55201000 Chemicals: Diversified | Other subject |
| 13 Apr 2023 17:45 CEST |
AZELIS GROUP NV | Azelis LTIP Share Buyback Program 2023 – Update | 55201000 Chemicals: Diversified | Other subject |
| 13 Apr 2023 17:45 CEST |
AZELIS GROUP NV | Azelis Group NV: Transparency notification | 55201000 Chemicals: Diversified | Other subject |
| 13 Apr 2023 17:45 CEST |
AZELIS GROUP NV | Azelis LTIP Aandeleninkoopprogramma 2023 - update | 55201000 Chemicals: Diversified | Other subject |
| 13 Apr 2023 08:00 CEST |
EURONAV | Euronav publiceert haar jaarverslag en formulier 20-F voor het boekjaar afgesloten op 31 december 2022 | 50206030 Marine Transportation | Other subject |
| 13 Apr 2023 08:00 CEST |
EURONAV | Euronav publishes its Annual Report and files Form 20-F for the year ended 31 December 2022 | 50206030 Marine Transportation | Other subject |
| 13 Apr 2023 07:00 CEST |
FAGRON | Sterk eerste kwartaal met 16% omzetgroei naar €181 miljoen | 20102010 Medical Equipment | Other subject |
| 13 Apr 2023 07:00 CEST |
FAGRON | Strong first quarter performance with 16% topline growth to €181 million | 20102010 Medical Equipment | Other subject |
| 12 Apr 2023 17:40 CEST |
NEXTENSA | Nextensa: Convocation à l’assemblée générale ordinaire des actionnaires du 15 mai 2023 | 35102030 Office REITs | General meeting / Board Meeting |